Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision line was updated from v3.6.2 to v3.6.3, reflecting a newer document revision. This is a metadata update and does not change substantive content.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page revision metadata was updated from v3.6.0 to v3.6.2. This indicates a minor software update to the site.SummaryDifference0.0%

- Check26 days agoChange DetectedNew study record date entries were added (2026-06-16, 2026-06-12, 2026-06) and older entries (2026-04-13, 2026-03-24, 2026-03) were removed, reflecting updates to the study's record log.SummaryDifference0.1%

- Check33 days agoChange DetectedRecruitment status note 'No longer looking for participants' was added to the page, signaling that enrollment is closed. The header formatting for the Interventions section was adjusted, and a new version stamp (Revision: v3.6.0) along with updated navigation/help sections were introduced.SummaryDifference0.3%

- Check41 days agoChange DetectedThe page now shows revision v3.5.5 instead of v3.5.4, indicating a newer version of the document. This update does not modify study details, eligibility criteria, or how the page operates.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new version of the page's documentation. This change does not modify the public content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.